Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187122 · ClinicalTrials.gov registry record · NA
Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma
A NA study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT00187122: Completed NA study, sponsored by St. Jude Children's Research Hospital.
NCT00187122 is a NA study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00187122, a NA study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The main purpose of this study is to determine if it is feasible to administer an intensified, multi-agent chemotherapy regimen for children with stage III and IV non-Hodgkin lymphoma and to find out what the toxicities are.
Interventions
- DRUG Vincristine
- DRUG Cytarabine
- PROCEDURE Radiation Therapy
- DRUG Daunomycin
- DRUG L-Asparaginase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 1993-03 |
| Est. Completion | 2004-06 |
| Phase | NA |
What the finished NCT00187122 record still lists
NCT00187122 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Vincristine is the first listed.
NCT00187122 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00187122 about?
NCT00187122 is a clinical study titled "Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma". The main purpose of this study is to determine if it is feasible to administer an intensified, multi-agent chemotherapy regimen for children with stage III and IV non-Hodgkin lymphoma and to find out what the toxicities are.
What is the current status of trial NCT00187122?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 1993-03. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00187122?
The interventions under investigation include: Vincristine (DRUG), Cytarabine (DRUG), Radiation Therapy (PROCEDURE), Daunomycin (DRUG), L-Asparaginase (DRUG).
Who is sponsoring clinical trial NCT00187122?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00187122's enrollment target sits among peer trials
42 1436th of 2000 higher than 555 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia